AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Docetaxel in South Africa
35 products registered with SAHPRA — 27 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| HODEXEL 160 mg/8 ml | 56/26/0758 | Hetero Drugs South Africa (Pty) Ltd | active | 30 Jul 2029 |
| DOCETAXEL 80 mg/4 ml HETERO | 56/26/0760.757 | Hetero Drugs South Africa (Pty) Ltd | active | 30 Jul 2029 |
| DOCETAXEL 160 mg/8 ml HETERO | 560761.758 | Hetero Drugs South Africa (Pty) Ltd | active | 30 Jul 2029 |
| DOCETAXEL 20 mg/ml HETERO | 56/26/0759.756 | Hetero Drugs South Africa (Pty) Ltd | active | 30 Jul 2029 |
| HODEXEL 20 mg/ml | 56/26/0756 | Hetero Drugs South Africa (Pty) Ltd | active | 30 Jul 2029 |
| HODEXEL 80 mg/4 ml | 56/26/0757 | Hetero Drugs South Africa (Pty) Ltd | active | 30 Jul 2029 |
| CEDOCET 20 mg/2 ml | 56/26/0031.028 | Aurogen South Africa (Pty) Ltd | active | 20 Feb 2029 |
| OTAXEC 160 mg/16 ml | 56/26/0030 | Aurogen South Africa (Pty) Ltd | active | 20 Feb 2029 |
| OTAXEC 80 mg/8 ml | 56/26/0029 | Aurogen South Africa (Pty) Ltd | active | 20 Feb 2029 |
| CEDOCET 160 mg/16 ml | 56/26/0033.030 | Aurogen South Africa (Pty) Ltd | active | 20 Feb 2029 |
| OTAXEC 20 mg/2 ml | 56/26/0028 | Aurogen South Africa (Pty) Ltd | active | 20 Feb 2029 |
| CEDOCET 80 mg/8 ml | 56/26/0032.029 | Aurogen South Africa (Pty) Ltd | active | 20 Feb 2029 |
| DOCELEX 80 | 41/26/0159 | Cipla Medpro (Pty) Ltd | suspended | 18 Jul 2025 |
| DOCELEX 20 | 41/26/0158 | Cipla Medpro (Pty) Ltd | suspended | 18 Jul 2025 |
| ACCORD DOCETAXEL 80 | 44/26/0559 | Accord Healthcare (Pty) Ltd | suspended | 19 Jun 2025 |
| ACCORD DOCETAXEL 20 | 44/26/0558 | Accord Healthcare (Pty) Ltd | suspended | 19 Jun 2025 |
| DOCETERE 20 mg/1 ml RTU | 44/26/0098 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 21 May 2025 |
| KEY-DOCETAXEL 20 mg AND DILUENT SOLUTION | 45/26/0328 | Key Oncologics (Pty) Ltd | suspended | 21 May 2025 |
| DOCETERE 80 mg/4 ml RTU | 44/26/0099 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 21 May 2025 |
| KEY-DOCETAXEL 80 mg AND DILUENT SOLUTION | 45/26/0329 | Key Oncologics (Pty) Ltd | suspended | 21 May 2025 |
| INNOTERE 80 | 52/26/0203 | Innovata Pharmaceuticals | active | 1 Jan 1900 |
| DOCEFREZ 20 | 43/26/0793 | MSQ Pharma (Pty) Ltd | active | 1 Jan 1900 |
| DOCEFREZ 80 | 43/26/0794 | MSQ Pharma (Pty) Ltd | active | 1 Jan 1900 |
| AXTERE 20 | 44/26/0556 | RBC Pharmaceuticals (PTY) LTD | active | 1 Jan 1900 |
| DOCETAXEL ACCORD 160 | 49/26/0834 | Accord Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| DOCETAXEL ZYDUS 80 | 46/26/0262 | Zydus Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| DOCETAXEL ZYDUS 20 | 46/26/0263 | Zydus Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| TAXOCAN 80 | 46/26/0264 | Zydus Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| TAXOCAN 20 | 46/26/0265 | Zydus Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| ERIOX 80 | 42/26/0008 | Eurolab (Pty) Ltd | active | 1 Jan 1900 |
| ERIOX 20 | 42/26/0006 | Eurolab (Pty) Ltd | active | 1 Jan 1900 |
| CIPLA DOCETAXEL 80 | 41/26/0163 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
| AXTERE 80 | 44/26/0557 | Accord Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| CIPLA DOCETAXEL 20 | 41/26/0162 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
| INNOTERE 20 | 52/26/0202 | Innovata Pharmaceuticals | active | 1 Jan 1900 |
Docetaxel — SAHPRA Registration Details
SAHPRA (South Africa) has 35 registered products containing Docetaxel, of which 27 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Docetaxel registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.